Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Astrazeneca Plc ADR (AZN)

Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 245,684,560
  • Shares Outstanding, K 3,100,512
  • Annual Sales, $ 45,811 M
  • Annual Income, $ 5,955 M
  • 60-Month Beta 0.45
  • Price/Sales 5.28
  • Price/Cash Flow 14.44
  • Price/Book 6.44
Trade AZN with:

Options Overview Details

View History
  • Implied Volatility 23.80% ( +0.22%)
  • Historical Volatility 14.19%
  • IV Percentile 71%
  • IV Rank 52.05%
  • IV High 31.19% on 10/16/23
  • IV Low 15.77% on 05/28/24
  • Put/Call Vol Ratio 0.13
  • Today's Volume 4,506
  • Volume Avg (30-Day) 4,857
  • Put/Call OI Ratio 1.08
  • Today's Open Interest 121,738
  • Open Int (30-Day) 115,765

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.98
  • Number of Estimates 5
  • High Estimate 1.07
  • Low Estimate 0.90
  • Prior Year 1.08
  • Growth Rate Est. (year over year) -9.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
76.30 +2.39%
on 07/09/24
79.87 -2.19%
on 06/25/24
-1.47 (-1.85%)
since 06/14/24
3-Month
68.01 +14.86%
on 04/16/24
80.86 -3.39%
on 06/06/24
+9.39 (+13.66%)
since 04/15/24
52-Week
60.47 +29.19%
on 02/12/24
80.86 -3.39%
on 06/06/24
+10.74 (+15.94%)
since 07/14/23

Most Recent Stories

More News
1 'Strong Buy' Biotech Stock With 132% Upside Potential

Analysts expect this small-cap biotech stock to more than double in value as it integrates AI into its drug development process.

ABSI : 3.95 (-1.99%)
MS : 105.26 (+1.12%)
AZN : 78.12 (-1.41%)
ALM.E.DX : 9.185 (-2.13%)
3 No-Brainer Stocks to Buy for Under $100 Right Now

You won't need much money to start investing in these great stocks.

AZN : 78.12 (-1.41%)
BMY : 40.15 (-0.77%)
PFE : 29.10 (+0.62%)
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GOVX),(NYSE:GSK),(NASDAQ:AZN),(NYSE:MRK) EQNX::TICKER_END

ONCY : 1.0800 (+3.85%)
ONC.TO : 1.49 (+3.47%)
GOVX : 2.81 (+1.08%)
GSK : 38.67 (-1.25%)
AZN : 78.12 (-1.41%)
MRK : 128.12 (+0.28%)
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth

ONCY : 1.0800 (+3.85%)
ONC.TO : 1.49 (+3.47%)
GOVX : 2.81 (+1.08%)
GSK : 38.67 (-1.25%)
AZN : 78.12 (-1.41%)
MRK : 128.12 (+0.28%)
From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data

/CNW/ -- USA News Group – This year's 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO) has now come and gone, but not without increasing...

ONCY : 1.0800 (+3.85%)
ABBV : 168.03 (-1.32%)
AZN : 78.12 (-1.41%)
PFE : 29.10 (+0.62%)
BMY : 40.15 (-0.77%)
ONC.TO : 1.49 (+3.47%)
Key Takeaways from the 2024 ASCO Annual Meeting: Promising Developments in Cancer Care

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – This year’s 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO) has now come and gone, but not...

ONCY : 1.0800 (+3.85%)
ONC.TO : 1.49 (+3.47%)
ABBV : 168.03 (-1.32%)
AZN : 78.12 (-1.41%)
PFE : 29.10 (+0.62%)
BMY : 40.15 (-0.77%)
How Is Bristol-Myers Squibb's Stock Performance Compared to Other General Drug Manufacturers?

Bristol-Myers Squibb has been lagging behind other drug manufacturers over the past three months, and analysts remain cautious about the stock's prospects.

BMY : 40.15 (-0.77%)
XPH : 41.76 (+0.26%)
AZN : 78.12 (-1.41%)
Is Pfizer Stock Underperforming the Nasdaq?

Pfizer has recently lagged the Nasdaq Composite, but analysts are optimistic about the stock’s prospects.

PFE : 29.10 (+0.62%)
$NASX : 18,472.57 (+0.40%)
AZN : 78.12 (-1.41%)
1 Biopharma Stock Setting the New Standard in Cancer Care Drugs

The annual conference of the American Society of Clinical Oncology is always the biggest event-making cancer conference. And this year, the attention-grabber was AstraZeneca, as its lung and breast cancer...

AZN : 78.12 (-1.41%)
DSNKY : 37.9900 (-0.03%)
MS : 105.26 (+1.12%)
PFE : 29.10 (+0.62%)
The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.

There's probably a big enough pie here for everyone to get a slice.

LLY : 950.46 (+0.22%)
AMGN : 330.15 (-0.21%)
AZN : 78.12 (-1.41%)
VKTX : 59.38 (+3.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition...

See More

Key Turning Points

3rd Resistance Point 80.24
2nd Resistance Point 80.01
1st Resistance Point 79.63
Last Price 78.12
1st Support Level 79.02
2nd Support Level 78.79
3rd Support Level 78.41

See More

52-Week High 80.86
Last Price 78.12
Fibonacci 61.8% 73.07
Fibonacci 50% 70.67
Fibonacci 38.2% 68.26
52-Week Low 60.47

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar